This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-005949-8po9xe5g | Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? |
| cord-018225-dozmy3lb | a clue to the susceptibility of jaundiced patients to shock? |
| cord-018801-amet0wx4 | Implications for Therapy Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome Management of the critically ill patient with cirrhosis: a multidisciplinary perspective Improved analgesia, sedation and delirium protocol associated with decreased duration of delirium and mechanical ventilation Dexmedetomidine vs. midazolam or propofol for sedation during prolonged ventilation Fast tracking in liver transplanatation: which patient benefits from this approach? |
| cord-033821-i14dmmps | -a randomized open- label controlled study Antifibrotics in liver disease: are we getting closer to clinical use? |
| cord-005892-3yuznrdv | Acute- on- chronic liver failure Toward an improved definition of acute- on- chronic liver failure Survival in infectionrelated acute- on- chronic liver failure is defined by extrahepatic organ failures Acute- on- chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Lessons from look- back in acute liver failure? |
| cord-275637-ea6w2kqv | bioRxiv Non- alcoholic fatty liver diseases in patients with COVID-19: A retrospective study COVID-19 and drug- induced liver injury: a problem of plenty or a petty point? |
| cord-001567-3bw7jbzq | Mitochondrial creatine kinase as a tumor- associated marker Elevated creatine kinase activity in primary hepatocellular carcinoma Different behavior of agmatine in liver mitochondria: inducer of oxidative stress or scavenger of reactive oxygen species? |
| cord-016880-q44623s8 | -what are we waiting for? |
| cord-016880-q44623s8 | temporary hepatic support by auxiliary orthotopic liver transplantation enables long- term success Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients Split liver transplantation Domino liver transplantation Donor evaluation and hepatectomy for living- donor liver transplantation Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small- for- size graft problems? |
| cord-309795-2kozsv4z | A Systematic Review and Meta- Analysis Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes EASL- EASD- EASO Clinical Practice Guidelines for the management of non- alcoholic fatty liver disease EASL- EASD- EASO clinical practice guidelines for the management of non- alcoholic fatty liver disease in severely obese people: do they lead to over- referral? |
| cord-309795-2kozsv4z | Promising Therapeutic Target? |
| cord-261608-4sjlg0p0 | A CLINICAL DISTRACTION? |
| cord-328147-61gtx2h2 | 2 What Has the COVID-19 Pandemic Taught Us so Far? |
| cord-328147-61gtx2h2 | Time for screening? |
| cord-340710-dmow5p7k | Lapping or biting? |
| cord-018414-6ffhm895 | Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation Does aprotinin really reduce blood loss in orthotopic liver transplantation? |
| cord-018414-6ffhm895 | Living related and split donors Fast tracking in liver transplantation: which patient benefits from this approach? |
| cord-018414-6ffhm895 | Primary pulmonary hypertension and cirrhosis: are they related? |
| cord-017603-wq4cgqs2 | A 20-year single- center experience with acute liver failure during pregnancy: is the prognosis really worse? |
| cord-017603-wq4cgqs2 | Neonatal hemochromatosis: is it an alloimmune disease? |
| cord-017603-wq4cgqs2 | to be or not to be? |
| cord-327601-4uqgwlnx | authors: Bangash, Mansoor N.; Patel, Jaimin M.; Parekh, Dhruv; Murphy, Nicholas; Brown, Rachel M.; Elsharkawy, Ahmed M.; Mehta, Gautam; Armstrong, Matthew J.; Neil, Desley title: SARS- CoV-2: is the liver merely a bystander to severe disease? |
| cord-016130-5q9ufu28 | Could synergistic interactions among reactive oxygen species, proteinases, membraneperforating enzymes, hydrolases, microbial hemolysins and cytokines be the main cause of tissue damage in infectious and inflammatory conditions? |
| cord-016130-5q9ufu28 | Substances affirmed as generally recognized as safe: Menhaden oil Upper respiratory tract infections in young children: duration of and frequency of complications Chronic sinusitis: a medical or surgical disease? |
| cord-016130-5q9ufu28 | The common cod Overfishing imposes a heavy toll PCBs and dioxins- Food Standards Agency statement-16 Dioxin levels down, fish oil supplement survey finds- Food Standards Agency Does mercury matter? |
| cord-016130-5q9ufu28 | They were then faced with the same question that perplexed Mellanby: Was the anti- rachitic factor vitamin A, or was it another substance with a similar distribution as fat- soluble vitamin A( 103)? |
| cord-290412-m6fesoyb | A prospective cohort study on the influence of high doses of herbs for clearing heat and resolving stasis on survival rates in patients with hepatitis B- related acute- on- chronic liver failure Clinical observation of clearing heat and removing dampness, cooling blood and detoxicating therapy for acute on chronic liver failure in hepatitis B. Beijing Zhong Yi Yao Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review Liver cirrhosis Procollagen III levels in serum: do they provide additional information in liver disease? |
| cord-290412-m6fesoyb | Reversal of hepatic fibrosis-fact or fantasy? |
| cord-030369-4dn02a35 | If the strict definition of acute and subacute liver failure as"no past history of liver disease"is executed, how to name the patients who had a history of chronic liver disease( caused by HBV from mother to child transmission in China)? |
| cord-030369-4dn02a35 | When should"I"consider a new hepatitis B virus genotype? |
| cord-030369-4dn02a35 | is tenofovir the answer? |
| cord-340325-0oh40b6r | From NIS to mNIS+ 7 Translate Bio Announces FDA Clearance to Proceed with a Single- ascending Dose( SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase( OTC) Deficiency, GlobeNewswire News Room Long- term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia Current issues of RNAi therapeutics delivery and development Mechanism of nanoparticle- induced hypersensitivity in pigs: complement or not complement? |
| cord-353633-a4pu6rlu | Could inflammatory markers help diagnose nonalcoholic steatohepatitis? |
| cord-332827-gll4nqdd | Angiotensin- converting enzyme 2: an ally or a Trojan horse? |
| cord-332827-gll4nqdd | EASL- ESCMID position paper Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? |
| cord-318755-fip8wj6y | Liver transplantation in an ICU dominated by COVID-19 Is a mandatory intensive care unit stay needed after liver transplantation? |
| cord-318755-fip8wj6y | Virtually Perfect? |
| cord-318755-fip8wj6y | Why does living donor liver transplantation flourish in Asia? |
| cord-029138-avfvpqs5 | One question to be answered is whether transplant centers will be willing to travel substantial distances for DCD livers? |
| cord-029138-avfvpqs5 | The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story Liver transplantation using donation after cardiac death donors: long- term follow- up from a single center A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-an analysis of the national registry Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity- matched cohort Liver transplantation using grafts from donors after circulatory death: a propensity score- matched study from a single center Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy Report of the ad hoc committee of the Harvard medical school to examine the definition of brain death Experience with liver and kidney allografts from non- heart- beating donors Successful extrarenal transplantation from non- heart- beating donors Improving national results in liver transplantation using grafts from donation after cardiac death donors New national liver and intestinal organ transplant system in effect Feb Noneligible donors as a strategy to decrease the organ shortage This article describes the wide varyance in DCD liver graft utilization and suggests potential reasons for why this variance in seen United States donation after circulatory death liver transplantation is driven by a few high- utilization transplant centers Intraregional model for end- stage liver disease score variation in liver transplantation: disparity in our own backyard Going the distance for procurement of donation after circulatory death livers for transplantation- Does reimbursement reflect reality? |
| cord-029138-avfvpqs5 | The super- rapid technique in Maastricht category III donors: has it developed enough for marginal liver grafts from donors after cardiac death? |
| cord-029138-avfvpqs5 | The use of donation after cardiac death allografts does not increase recurrence of hepatocellular carcinoma Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure- free survival Developing a donation after cardiac death risk index for adult and pediatric liver transplantation Impact of donor age in donation after cardiac death liver transplantation: is the cut- off"60"still of relevance? |
| cord-284693-mgpxnnk0 | -pre- or post- liver transplantation? |
| cord-284693-mgpxnnk0 | The Oral Ganciclovir International Transplantation Study Group Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir Who among cytomegalovirus- seropositive liver transplant recipients is at risk for cytomegalovirus infection? |
| cord-284693-mgpxnnk0 | current German practice Use of Everolimus- based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant Antiviral drug resistance of human cytomegalovirus Epstein- Barr virus infections: biology, pathogenesis, and management Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients Posttransplant lymphoproliferative disease following liver transplantation Occurrence of post- transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? |
| cord-342930-f7cw2ca6 | Are patients with hypertension and diabetes mellitus at 33 increased risk for COVID-19 infection? |
| cord-342930-f7cw2ca6 | Lapping or biting? |
| cord-342930-f7cw2ca6 | The Lancet Misguided drug advice for COVID-19 Characteristics of and Public Health Responses to the Coronavirus Disease 36 2019 Outbreak in China Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or 38 Foe? |
| cord-271635-tydlyc1q | Can methanolic extract of Nigella sativa seed affect glyco- regulatory enzymes in experimental hepatocellular carcinoma? |
| cord-271635-tydlyc1q | Resveratrol down- regulates Myosin light chain kinase, induces apoptosis and inhibits diethylnitrosamine- induced liver tumorigenesis in rats Inflammation and cancer: back to Virchow? |
| cord-271635-tydlyc1q | What do we know so far? |
| cord-271635-tydlyc1q | a potential biomarker of mitochondrial dysfunction? |
| cord-016757-3d320c0a | A case report Role of plasmapheresis in the management of acute hepatic failure in children A new procedure for the removal of protein bound drugs and toxins Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry Extracorporeal perfusion for the treatment of acute liver failure Reversal of fulminant hepatic failure using an extracorporeal liver assist device Which hepatocyte will it be? |
| cord-016757-3d320c0a | A treatable disorder? |
| cord-016757-3d320c0a | Are there histopathologic characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection? |
| cord-303046-unksl7p4 | COVID-19 and viral hepatitis elimination programs: are we stepping backward? |
| cord-303046-unksl7p4 | Patients with chronic liver disease do not seem to be at greater risk of acquiring the infection than other indivi duals in the general population, but the potential onset of COVID-19 in these patients raises two questions: will patients with chronic liver disease develop a more severe form of COVID-19; and will COVID-19 aggravate the course of their liver disease and induce liver- related mortality? |
| cord-032181-gmcugd8h | : What do we really know? |
| cord-032181-gmcugd8h | The pathophysiology of trauma- induced coagulopathy Laboratory evidence of hyperfibrinolysis in association with low PAI-1 activity Interventional algorithms for the control of coagulopathic bleeding in surgical, trauma, and postpartum settings: recommendations from the Share Network Group Hyperfibrinolysis and the risk of hemorrhage in stable cirrhotic patients Does negative heparin- platelet factor 4 enzymelinked immunosorbent assay effectively exclude heparin- induced thrombocytopenia? |
| cord-032181-gmcugd8h | The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide- induced acute liver injury and hepatic encephalopathy Is it worth removing albumin- bound substances in hepatic encephalopathy? |
| cord-018620-3kqx8arn | Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats Hemodynamic mechanism of esophageal varices Pathophysiology of portal hypertension and esophageal varices Portal hypertension and its complications Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? |
| cord-018620-3kqx8arn | Recent data on incidence and treatment Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? |
| cord-018620-3kqx8arn | The model for end- stage liver disease( MELD) MELD vs Child- Pugh and creatinine- modified Child- Pugh score for predicting survival in patients with decompensated cirrhosis MELD score is better than Child- Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt Comparison and improvement of MELD and Child- Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients Comparison of MELD, Child- Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting Systematic review: The model for end- stage liver disease-should it replace Child- Pugh's classification for assessing prognosis in cirrhosis? |
| cord-018620-3kqx8arn | The real capabilities of contrast- enhanced ultrasound in the characterization of solid focal liver lesions Noninvasive tests for liver disease, fibrosis, and cirrhosis: is liver biopsy obsolete? |
| cord-018620-3kqx8arn | Too much lactate or too little liver? |
| cord-279667-ikfduu2k | Clinical manifestations and outcome of SARS- CoV-2 infection during pregnancy Maternal Deaths with Covid19: a different outcome from mid to low resource countries? |
| cord-279667-ikfduu2k | Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies Novel corona virus disease( COVID-19) in pregnancy: What clinical recommendations to follow? |
| cord-279667-ikfduu2k | Published Thursday 9 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-023033-tgt69ir6 | Following exposure to the T cell expander, the level of CD4+CD25+ T cells increased 4.5 times( 28.6 2 30.8) in normal controls, but only 1.85 times in AM-2 patients( 6.62? |
| cord-023033-tgt69ir6 | Full- length HCV cDNA corresponding to the pH77 strain previously shown to be infectious in the presence of? |
| cord-023033-tgt69ir6 | Ischemic preconditioning decreased serum ALT activity compared to control( 168? |
| cord-023033-tgt69ir6 | SEMI vs 333? |
| cord-023033-tgt69ir6 | p= O.O2), a difference present both at diagnosis( 2.24? 0.56, p<0.005) and during remission( 4.25 2 0.35, p= O.Ol). |
| cord-018318-vzzrsqsn | ? Impact of hepatic vein deprivation on liver regeneration after major hepatectomy Loss of NF- kB activation in Kupffer cell- depleted mice impairs liver regeneration after partial hepatectomy |
| cord-018318-vzzrsqsn | Hypercoagulability, hypocoagulability or normocoagulability? |
| cord-018318-vzzrsqsn | Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma Kidney failure following liver resection Frailty as a predictor of surgical outcomes in older patients Analysis of morbidity and mortality rates in right hepatectomy with the preoperative APACHE II score Should hepatic resections be performed at high- volume referral centers? |
| cord-018318-vzzrsqsn | Where do we stand? |
| cord-018318-vzzrsqsn | artifi cial extracorporeal liver support-- how does Prometheus compare with MARS? |
| cord-025168-be7zube4 | Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9 Nonhematopoietic mesenchymal stem cells: what are they? |
| cord-025168-be7zube4 | Human fetal membranes: a source of stem cells for tissue regeneration and repair? |
| cord-025168-be7zube4 | In vitro and In vivo evaluation of osteogenesis of human umbilical cord blood- derived mesenchymal stem cells on partially demineralized bone matrix Adipose tissue- derived mesenchymal stem cells as a source of human hepatocytes Mesenchymal stem cells in the Wharton's Jelly of the human umbilical cord Wharton's Jelly derived mesenchymal stem cells: future of regenerative medicine? |
| cord-025168-be7zube4 | What's new in acute liver failure? |
| cord-025168-be7zube4 | over Ready to submit your research? |
| cord-340576-dabcs3w5 | A Randomized Trial Is Lactulose Plus Rifaximin Better Than Lactulose Alone in the Management of Hepatic Encephalopathy? |
| cord-340576-dabcs3w5 | Far? |
| cord-340576-dabcs3w5 | Is Associated With Cirrhosis and Its Complications Short Chain Fatty Acids Exchange: Is the Cirrhotic, Dysfunctional Liver Still Able to Clear Them? |
| cord-340576-dabcs3w5 | Microbiota- driven Gut Vascular Barrier Disruption Is a Prerequisite for Non- Alcoholic Steatohepatitis Development Increased intestinal permeability and decreased barrier function: Does it really influence the risk inflammation? |
| cord-340576-dabcs3w5 | No Effect of Rifaximin on Soluble CD163, Mannose Receptor or Type III and IV Neoepitope Collagen Markers in Decompensated Cirrhosis: Results From a Randomized Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat? |
| cord-340576-dabcs3w5 | Pathophysiological Basis for Therapy Gut Flora- Based Therapy in Liver Disease? |
| cord-340576-dabcs3w5 | Sarcopenia Associated With Hepatic Encephalopathy in Liver Cirrhosis? |
| cord-340576-dabcs3w5 | What relevance for health? |
| cord-022754-ehq9qnoo | A review Breed, sex and age distribution in dogs with chronic liver disease: a demographic study Chronic hepatitis in Cocker Spaniels- another syndrome? |
| cord-022754-ehq9qnoo | Fad or future of liver disease? |
| cord-022754-ehq9qnoo | Information provided by a scintigram is a"yes"or"no"answer to the question: Does the patient have portosystemic shunting? |
| cord-022754-ehq9qnoo | Is hepatic impairment a clue to pathogenesis? |
| cord-022754-ehq9qnoo | Statistical relevance of ultrasonographic criteria in the assessment of diffuse liver disease in dogs and cats Can sonographic findings predict the results of liver aspirates in dogs with suspected liver disease? |
| cord-022754-ehq9qnoo | The pathology of liver tumours in the dog Partial hepatectomy in dogs Cancer of the liver Efficacy of mitoxantrone against various neoplasms in dogs Low- dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells? |
| cord-022754-ehq9qnoo | The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs Chronic active hepatitis with cirrhosis in the Doberman Pinscher Hepatic copper concentrations in Labrador Retrievers with and without chronic hepatitis( 1980- 2008): an emerging syndrome or oversupplementation? |
| cord-022754-ehq9qnoo | With suspected drug- or toxin- induced liver disease, a liver biopsy can be helpful to( a) characterize the histologic changes( are they consistent with previously described lesions caused by this particular drug or toxin?),( b) determine the severity( focal or diffuse necrosis?) or reversibility( is cirrhosis present?) of the lesions for prognostic purposes, and( c) rule out known causes of liver disease. |
| cord-022754-ehq9qnoo | With suspected drug- or toxin- induced liver disease, a liver biopsy can be helpful to( a) characterize the histologic changes( are they consistent with previously described lesions caused by this particular drug or toxin?),( b) determine the severity( focal or diffuse necrosis?) or reversibility( is cirrhosis present?) of the lesions for prognostic purposes, and( c) rule out known causes of liver disease. |
| cord-022754-ehq9qnoo | With suspected drug- or toxin- induced liver disease, a liver biopsy can be helpful to( a) characterize the histologic changes( are they consistent with previously described lesions caused by this particular drug or toxin?),( b) determine the severity( focal or diffuse necrosis?) or reversibility( is cirrhosis present?) of the lesions for prognostic purposes, and( c) rule out known causes of liver disease. |
| cord-023017-k6edtg58 | ( I? |
| cord-023017-k6edtg58 | 12mmHg or by? |
| cord-023017-k6edtg58 | 12mmHg or? lo%), had a significantly lower probability of bleeding( P?O.Ol) and of requiring hospital admission because decompensations of cirrhosis, while survival probability was higher, both after acute and chronic beta- blocker administration. |
| cord-023017-k6edtg58 | 2) what are the risk factors of IR; 3) does IR play a role( and to what extent) in the occurrence of steatosis? |
| cord-023017-k6edtg58 | 20% in 38% of cases and decreased? lo% in 74%( P?O.OOl) after acute beta- blocker. |
| cord-023017-k6edtg58 | 4) is IR involved in the progression of fibrosis? |
| cord-023017-k6edtg58 | Control( 0.65 cellsltriad? |
| cord-023017-k6edtg58 | Hemodynamic responders( defining response as a decrease of HVPG to? |
| cord-023017-k6edtg58 | If CD34 numbers are adjusted for the total mononuclear cell counts then the increase in circulating stem cells between these two groups became even more apparent( 0.44? 0.34 and 4.98XlOX6 cellsll 24.8; p<0.05). |
| cord-023017-k6edtg58 | In patients with chronic hepatitis C, we adressed the following issues: 1) is IR the cause or consequence of steatosis and fibrosis? |
| cord-023017-k6edtg58 | Methods: Chronic liver injury was induced in rats by CC14 treatment( of the development of cirrhosis in Group 1( histopathology score of 3.7? |
| cord-023017-k6edtg58 | Our results suggest that: 1) A decrease of HVFG? |
| cord-023017-k6edtg58 | Overall, patients with PNF were older( 55.7 t 10 vs. 48.99 years, p=0.03) and had higher peak ALT levels( 141? 185 vs. 40 2 32 U/ L, p=0.04). |
| cord-023017-k6edtg58 | Studies dealing with the prevention of rebleeding have shown that hemodynamic response to pharmacological treatment of portal hypertension is adequate when the hepatic venous pressure gradient( HVPG) decreases to? |
| cord-023017-k6edtg58 | The HCV RNA was done by a PCR technique with a detectability cutoff of 50-copieslmb Results: Both randomized groups were similar at baseline without statistical significant difference, 190( 90%) were infected with genotype 4, mean age was 39.5 years? |
| cord-023017-k6edtg58 | The HVPG decreased? |
| cord-023017-k6edtg58 | The area of ASMA- positive cells was however significantly decreased by SSR 182289 from 3.83? 1.04 to 2.86 |
| cord-023017-k6edtg58 | The mean level of circulating apoptotic cells in Day 1 recipient PBMC was higher than healthy controls( 0.9% t-0.2 vs 0.2%? |
| cord-023017-k6edtg58 | Using ROC curve a decrease of HVPG? |
| cord-022555-a7ie82fs | Abdominal palpation should be performed to assess pain( where?), any masses( foreign bodies, lymph nodes, or even focally thickened intestines, such as with neoplasia), or turgid intestines. |
| cord-022555-a7ie82fs | Acute pancreatitis in cats with hepatic lipidosis Pancreatic atrophy and fibrosis associated with Eurytrema procyonis in a domestic cat Comparisons between cats with normal and increased fPLI concentrations in cats diagnosed with inflammatory bowel disease Pancreatolithiasis and pancreatic pseudobladder associated with pancreatitis in a cat Acinar cell carcinoma of the pancreas in a cat Laparotomy for gastro- intestinal biopsies Enteric bacteria: friend or foe? |
| cord-022555-a7ie82fs | Appearance of diarrhea Quantity and quality of the stool( color, consistency, character, presence of blood or mucus)? |
| cord-022555-a7ie82fs | Are any medications required? |
| cord-022555-a7ie82fs | Are lilies present in the house? |
| cord-022555-a7ie82fs | Are such patients best treated for inflammatory bowel disease, Helicobacter infection, or both? |
| cord-022555-a7ie82fs | Are there any dietary changes or indiscretion? |
| cord-022555-a7ie82fs | Are there any medications unaccounted for( e.g., a dropped aspirin tablet)? |
| cord-022555-a7ie82fs | Description of defecation process Tenesmus( straining) and dyschezia( painful defecation)? |
| cord-022555-a7ie82fs | Has the cat been seen playing with an insect, mouse, or other prey? |
| cord-022555-a7ie82fs | Important questions to ask concern frequency of defecation( and how this compares with the normal state), tenesmus( straining usually indicates large bowel diarrhea, since an irritated colon leads to urgency), volume of feces( smaller volumes are typical of large bowel diarrhea; larger volumes are more typical of small Onset and duration of diarrhea Acute versus chronic? |
| cord-022555-a7ie82fs | Is supportive care necessary? |
| cord-022555-a7ie82fs | Is the cat well or unwell? |
| cord-022555-a7ie82fs | Is there primary or secondary gastrointestinal disease? |
| cord-022555-a7ie82fs | Is there small or large bowel diarrhea? |
| cord-022555-a7ie82fs | The practitioner must ask the following important questions: • Are ancillary tests appropriate? |
| cord-022555-a7ie82fs | • Is there an acute onset or a chronic time course? |
| cord-000083-3p81yr4n | Between patients with HOMA- IR positive and negative, however, statistically no significant difference was found in terms of age, sex, etiology, Child- Pugh classification, spleen size, TNF-?, |
| cord-000083-3p81yr4n | Do we all failed in addressing socio- economic issues of cancer- sufferers? |
| cord-000083-3p81yr4n | IL-1? |
| cord-000083-3p81yr4n | IL-1? |
| cord-000083-3p81yr4n | IL-1? |
| cord-000083-3p81yr4n | IL-1? |
| cord-000083-3p81yr4n | In additon, we aimed to investigate the relation of insulin resistance in liver cirrhosis with such parameters as age, sex, etiology, Child- Pugh classification, spleen size, TNF-?, IL-1? |
| cord-000083-3p81yr4n | In additon, we aimed to investigate the relation of insulin resistance in liver cirrhosis with such parameters as age, sex, etiology, Child- Pugh classification, spleen size, TNF-?, IL-1? |
| cord-000083-3p81yr4n | In liver cirrhosis group, glucose, insulin, C- peptid, HOMA- IR, TNF-? |
| cord-000083-3p81yr4n | In patients with liver cirrhosis, the levels of glucose, insulin, C- peptid, HOMA- IR, TNF-?, IL-2RES, IL-6, CRP and Hs- CRP increase with respect to normal population. |
| cord-000083-3p81yr4n | In the study, it was also determined that the mechanism of insulin resistance development occurs independent of age, sex, etiology, Child- Pugh classification, spleen size, TNF-?, |
| cord-000083-3p81yr4n | The two groups were compared with each other in terms of glucose, insulin, C- peptid, HOMA- IR, TNF-?, |
| cord-000083-3p81yr4n | These two groups, i.e., HOMA- IR positive and HOMA- IR negative, were compared in terms of age, sex, etiology, Child- Pugh classification, spleen size, TNF-?, |